IP2
IP2 is a non-cytotoxic immunomodulator that promotes the presentation of Pioneer Translation Product (PTP) -derived antigens in cancer cells. It has demonstrated efficacy in impairing tumor growth in murine models, supporting its use in immuno-oncology research for both in vitro antigen presentation studies and in vivo therapeutic investigations.
Product Specifications
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog